UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

Value in health, 2014-11, Vol.17 (7), p.A526-A526

2014

Volltextzugriff (PDF)

Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

Value in health, 2014-11, Vol.17 (7), p.A622-A622

2014

Volltextzugriff (PDF)

Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

Value in health, 2013-11, Vol.16 (7), p.A400-A400

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Value in health, 2013-11, Vol.16 (7), p.A623-A623

2013

Volltextzugriff (PDF)

Disability adjusted life years lost due to diabetes in france, Italy, Germany, Spain and the United Kingdom: A burden of illness study

Value in health, 2014-05, Vol.17 (3), p.A262-A262

2014

Volltextzugriff (PDF)

PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

Value in health, 2012-11, Vol.15 (7), p.A327-A327

2012

Volltextzugriff (PDF)

PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

Value in health, 2012-11, Vol.15 (7), p.A328-A328

2012

Volltextzugriff (PDF)

POSC188 Analysis of Hospital Incidence and Direct Medical Costs of Intrahepatic Cholangiocarcinoma in Spain

Value in health, 2022-01, Vol.25 (1), p.S137-S137

2022

Volltextzugriff (PDF)

POSB185 Epidemiology and Management of Parathyroid Gland Disorders in Spain over 15 Years: A Retrospective Multicenter Analysis

Value in health, 2022-01, Vol.25 (1), p.S130-S130

2022

Volltextzugriff (PDF)

POSB184 Hospital Incidence, Mortality and Costs of Alzheimer's Disease in Spain: A Retrospective Multicenter Study

Value in health, 2022-01, Vol.25 (1), p.S130-S130

2022

Volltextzugriff (PDF)

PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

Value in health, 2011, Vol.14 (7), p.A489-A489

2011

Volltextzugriff (PDF)

PDG28 Future Projections of Opioids Utilization and Cost in Patient with Chronic Osteoarthritis PAIN in Spain

Value in health, 2020-12, Vol.23, p.S525-S525

2020

Volltextzugriff (PDF)

A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with Inhibitors

Value in health, 2013-11, Vol.16 (7), p.A379-A379

2013

Volltextzugriff (PDF)

PND132 CLAIMS DATABASE ANALYSIS OF HEADACHE AND MIGRAINE IN SPAIN 2011-2016: PATIENT PROFILE, HEALTHCARE MANAGEMENT AND DIRECT MEDICAL COSTS

Value in health, 2019-11, Vol.22, p.S762-S762

2019

Volltextzugriff (PDF)

PDB123 CURRENT STATUS AND USE OF RESOURCES OF LYSOSOMAL STORAGE DISEASES: ANALYSIS OF A SPANISH CLAIMS DATABASE

Value in health, 2019-11, Vol.22, p.S595-S595

2019

Volltextzugriff (PDF)

PCN516 EXPLORING THE CURRENT STATUS OF NEUROENDOCRINE TUMOURS: A POPULATION-BASED ANALYSIS OF EPIDEMIOLOGY, MANAGEMENT AND USE OF RESOURCES

Value in health, 2019-11, Vol.22, p.S538

2019

Volltextzugriff (PDF)

PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

Value in health, 2011, Vol.14 (7), p.A371-A372

2011

Volltextzugriff (PDF)

PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

Value in health, 2012-11, Vol.15 (7), p.A542-A542

2012

Volltextzugriff (PDF)

PSY8 Neuropathic Pain: a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market

Value in health, 2011, Vol.14 (7), p.A411-A411

2011

Volltextzugriff (PDF)

PMS48 Cost-Utility of Denosumab for the Treatment of Postmenopausal Osteoporosis in Spain

Value in health, 2011, Vol.14 (7), p.A311-A311

2011

Volltextzugriff (PDF)

PRS16 Cost Analysis of Haemostatic Treatment with a Fibrin-Based Sponge Versus Fibrin Sealant in Lung Surgery and Liver Resection in a Spanish Setting

Value in health, 2011, Vol.14 (7), p.A490-A490

2011

Volltextzugriff (PDF)

PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal

Value in health, 2011, Vol.14 (7), p.A452-A452

2011

Volltextzugriff (PDF)

PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated Cohort

Value in health, 2011, Vol.14 (7), p.A435-A436

2011

Volltextzugriff (PDF)

PSY151 - Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

Value in health, 2017-10, Vol.20 (9), p.A571-A571

2017

Volltextzugriff (PDF)

Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

Value in health, 2017-10, Vol.20 (9), p.A571

2017

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieValue In Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(85)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Blackwell Single Titles
(85)
EZB Electronic Journals Library
(85)
Ovid
(85)
Ingenta
(85)
Elsevier ScienceDirect Journals Complete
(85)
Applied Social Sciences Index & Abstracts (ASSIA)
(2)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Qutenza® Estimated Costs Per Patient In Primary Versus Secondary Care. A Comparison Between Qutenza®, Pregabalin and Lidocaine for the Treatment of Peripheral Neuropathic Pain

Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission

Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study

Disability adjusted life years lost due to diabetes in france, Italy, Germany, Spain and the United Kingdom: A burden of illness study

PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in Spain

PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

POSC188 Analysis of Hospital Incidence and Direct Medical Costs of Intrahepatic Cholangiocarcinoma in Spain

POSB185 Epidemiology and Management of Parathyroid Gland Disorders in Spain over 15 Years: A Retrospective Multicenter Analysis

POSB184 Hospital Incidence, Mortality and Costs of Alzheimer's Disease in Spain: A Retrospective Multicenter Study

PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

PDG28 Future Projections of Opioids Utilization and Cost in Patient with Chronic Osteoarthritis PAIN in Spain

A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with Inhibitors

PND132 CLAIMS DATABASE ANALYSIS OF HEADACHE AND MIGRAINE IN SPAIN 2011-2016: PATIENT PROFILE, HEALTHCARE MANAGEMENT AND DIRECT MEDICAL COSTS

PDB123 CURRENT STATUS AND USE OF RESOURCES OF LYSOSOMAL STORAGE DISEASES: ANALYSIS OF A SPANISH CLAIMS DATABASE

PCN516 EXPLORING THE CURRENT STATUS OF NEUROENDOCRINE TUMOURS: A POPULATION-BASED ANALYSIS OF EPIDEMIOLOGY, MANAGEMENT AND USE OF RESOURCES

PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

PSY8 Neuropathic Pain: a Budget Impact Analysis to Estimate Costs Due to the Introduction of Qutenza® on the Spanish Market

PMS48 Cost-Utility of Denosumab for the Treatment of Postmenopausal Osteoporosis in Spain

PRS16 Cost Analysis of Haemostatic Treatment with a Fibrin-Based Sponge Versus Fibrin Sealant in Lung Surgery and Liver Resection in a Spanish Setting

PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal

PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated Cohort

PSY151 - Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

Aktive Filter

Suchergebnisse filtern